Delcath Systems Inc

DCTHNASDAQ · USD
15.93USD+0.08 (+0.51%)
5510

Delcath Systems Inc (DCTH) Covered Calls

As of September 29, 2026, DCTH has 8 covered call opportunities in the coming three months. Return ranges from 11.0 to 40.9% until expiration. Annualized return ranges from 23.0 to 182.6%. The nearest expiration is October 16, 2026. Maximum potential profit is $657.

Read more

Running DCTH covered calls helps you generate consistent income from Delcath Systems Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Delcath Systems Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best DCTH covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.

A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if DCTH stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling DCTH covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Delcath Systems Inc covered call is worth writing.

Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with metastatic hepatic dominant Uveal Melanoma to investigate objective response rate in metastatic uveal melanoma. It also provides HEPZATO as a stand-alone medical device under the CHEMOSAT Hepatic Delivery System trade name for Melphalan or CHEMOSAT for medical centers to treat a range of liver cancers in Europe.

Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York.

Income-focused investors, long-term DCTH holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling DCTH covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Delcath Systems Inc covered calls come to you, already filtered for the metrics that matter.

Stock Statistics

  • IndustryMedical Devices
  • SectorHealthcare
  • IV percentile71.83% Elevated
  • Market cap (M$)550
  • 52 weeks high-9.01%
  • 52 weeks low95.20%
  • Analyst recommendationStrong Buy
    1.00
  • Target price$24.50
    53.80% above the current stock price
  • Dividend—
  • Payout ratio0.00%
  • Earnings date2026-11-03
  • P/E2,598.36
  • Future P/E—
  • EPS (ttm)0.01
  • EPS growth next 5 years37.00%

As of September 29, 2026

2026-10-162217.508.830.351.45177.0011.01182.62-2.18+0.40281.10
2026-11-205720.0024.380.200.85412.0025.62164.07-1.24+0.24700.65
2027-02-1914822.5039.930.152.10657.0040.86100.77-0.93+0.31161.95
2027-02-1914820.0024.381.052.15497.0030.9176.23-6.53+0.40591.10
2027-05-2123922.5039.930.104.00652.0040.5561.92-0.62+0.4113.90
2027-05-2123920.0024.381.852.85577.0035.8854.80-11.50+0.4741.00
2027-02-1914817.508.832.102.55352.0021.8953.99-13.06+0.521260.45
2027-05-2123917.508.831.005.20242.0015.0522.98-6.22+0.5704.20

As of September 29, 2026

Sell covered calls with the data behind you

Find the best DCTH covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.

Start your 14-day free trial